C. Franceschi and J. Campisi, Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases, J Gerontol A Biol Sci Med Sci, vol.69, issue.1, pp.4-9, 2014.

T. A. Pearson, G. A. Mensah, R. W. Alexander, J. L. Anderson, R. O. Cannon et al., Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare, American Heart Association. Circulation, vol.107, pp.499-511, 2003.

P. M. Ridker, J. E. Buring, N. R. Cook, and N. Rifai, Creactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women, Circulation, vol.107, pp.391-397, 2003.

A. Koyama, J. O'brien, J. Weuve, D. Blacker, A. L. Metti et al., The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a metaanalysis, J Gerontol A Biol Sci Med Sci, vol.68, pp.433-440, 2013.

P. Soysal, B. Stubbs, P. Lucato, C. Luchini, M. Solmi et al., Inflammation and frailty in the elderly: A systematic review and meta-analysis, 2016.

, Ageing Res Rev, vol.31, pp.1-8

R. R. Yang, B. C. Lu, T. Li, Y. F. Du, X. Wang et al., The relationship between high-sensitivity C-reactive protein at admission and post stroke depression: a 6-month follow-up study, Int J Geriatr Psychiatry, vol.31, pp.231-239, 2016.

P. Courtet, I. Jaussent, C. Genty, A. M. Dupuy, S. Guillaume et al., Increased CRP levels may be a trait marker of suicidal attempt, Eur Neuropsychopharmacol, vol.25, pp.1824-1831, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01988159

C. L. Satizabal, Y. C. Zhu, B. Mazoyer, C. Dufouil, and C. Tzourio, Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study, Neurology, vol.78, pp.720-727, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01166212

D. A. Fleischman, K. Arfanakis, J. F. Kelly, N. Rajendran, A. S. Buchman et al., Regional brain cortical thinning and systemic inflammation in older persons without dementia, J Am Geriatr Soc, vol.58, pp.1823-1825, 2010.

A. L. Jefferson, J. M. Massaro, P. A. Wolf, S. Seshadri, R. Au et al., Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study, Neurology, vol.68, pp.1032-1038, 2007.

J. Miralbell, J. J. Soriano, G. Spulber, E. Lopez-cancio, J. F. Arenillas et al., Structural brain changes and cognition in relation to markers of vascular dysfunction, Neurobiol Aging, vol.33, pp.1003-1009, 2012.

H. Wersching, T. Duning, H. Lohmann, S. Mohammadi, C. Stehling et al., Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function, Neurology, vol.74, pp.1022-1029, 2010.

K. Arfanakis, D. A. Fleischman, G. Grisot, C. M. Barth, A. Varentsova et al., Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition, PLoS One, vol.8, p.73107, 2013.

M. Bellani, P. H. Yeh, M. Tansella, M. Balestrieri, J. C. Soares et al., DTI studies of corpus callosum in bipolar disorder, Biochem Soc Trans, vol.37, pp.1096-1098, 2009.

D. Paola, M. , D. Iulio, F. Cherubini, A. Blundo et al., When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study, Neurology, vol.74, pp.1136-1142, 2010.

D. Arnone, A. M. Mcintosh, P. Chandra, and K. P. Ebmeier, Meta-analysis of magnetic resonance imaging studies of the corpus callosum in bipolar disorder, Acta Psychiatr Scand, vol.118, pp.357-362, 2008.

F. Cyprien, P. Courtet, V. Poulain, J. Maller, C. Meslin et al., Corpus callosum size may predict late-life depression in women: a 10-year follow-up study, J Affect Disord, vol.165, pp.16-23, 2014.

F. Cyprien, P. Courtet, A. Malafosse, J. Maller, C. Meslin et al., Suicidal behavior is associated with reduced corpus callosum area, Biol Psychiatry, vol.70, pp.320-326, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00841564

C. Lebel, M. Gee, R. Camicioli, M. Wieler, W. Martin et al., Diffusion tensor imaging of white matter tract evolution over the lifespan, Neuroimage, vol.60, pp.340-352, 2012.

K. Ritchie, S. Artero, I. Beluche, M. L. Ancelin, A. Mann et al., Prevalence of DSM-IV psychiatric disorder in the French elderly population, Br J Psychiatry, vol.184, pp.147-152, 2004.

J. Talairach and . Tp, Referentially Oriented Cerebral MRI Anatomy: Atlas of Stereotaxic Anatomical Correlations for Gray and White Matter, 1993.

J. Sun, J. J. Maller, Z. J. Daskalakis, C. C. Furtado, and P. B. Fitzgerald, Morphology of the corpus callosum in treatment-resistant schizophrenia and major depression, Acta Psychiatr Scand, vol.120, pp.265-273, 2009.

C. Ryberg, E. Rostrup, M. B. Stegmann, F. Barkhof, P. Scheltens et al., Clinical significance of corpus callosum atrophy in a mixed elderly population, Neurobiol Aging, vol.28, pp.955-963, 2007.

M. Mortamais, C. Reynes, A. M. Brickman, F. A. Provenzano, J. Muraskin et al., Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia, PLoS One, vol.8, p.56972, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00916484

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, pp.189-198, 1975.

L. Radloff, The CES-D Scale: A self report depression scale for research in the general population, Applied Psychological Measurement, vol.1, pp.385-401, 1977.

B. M. Bettcher, C. L. Watson, C. M. Walsh, I. V. Lobach, J. Neuhaus et al., Interleukin-6, age, and corpus callosum integrity, PLoS One, vol.9, p.106521, 2014.

S. P. Mazer and L. E. Rabbani, Evidence for Creactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP, J Thromb Thrombolysis, vol.17, pp.95-105, 2004.

J. Zacho, A. Tybjaerg-hansen, J. S. Jensen, P. Grande, H. Sillesen et al., Genetically elevated C-reactive protein and ischemic vascular disease, N Engl J Med, vol.359, pp.1897-1908, 2008.

D. Y. Lee, E. Fletcher, O. Martinez, N. Zozulya, J. Kim et al., Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease, Stroke, vol.41, pp.1791-1797, 2010.

A. D. Roth, G. Ramirez, R. Alarcon, V. Bernhardi, and R. , Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation, Biol Res, vol.38, pp.381-387, 2005.